Daisuke Sugiura

2.3k total citations · 1 hit paper
21 papers, 1.7k citations indexed

About

Daisuke Sugiura is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daisuke Sugiura has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Daisuke Sugiura's work include Cancer Immunotherapy and Biomarkers (14 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (10 papers). Daisuke Sugiura is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (10 papers). Daisuke Sugiura collaborates with scholars based in Japan, United States and Indonesia. Daisuke Sugiura's co-authors include Il‐mi Okazaki, Taku Okazaki, Takumi Maruhashi, Kenji Shimizu, Tatsuya Takemoto, Tomoo Eto, Tasuku Honjo, Masamichi Muramatsu, Taku Yoshida and Jian Wang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Daisuke Sugiura

21 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice

2011 255 citations Taku Okazaki, Il‐mi Okazaki et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daisuke Sugiura Japan	14	1.2k	1.1k	302	133	74	21	1.7k
Joë-Marc Chauvin United States	10	1.3k 1.1×	1.3k 1.1×	326 1.1×	157 1.2×	65 0.9×	16	1.8k
Sonia Pastor France	14	857 0.7×	946 0.8×	229 0.8×	96 0.7×	93 1.3×	22	1.4k
Victor H. Salinas United States	6	989 0.9×	1.2k 1.0×	308 1.0×	146 1.1×	96 1.3×	12	1.8k
Jiacheng Bi China	18	976 0.8×	1.4k 1.2×	304 1.0×	84 0.6×	53 0.7×	30	1.9k
Junrong Xia United States	6	842 0.7×	1.6k 1.4×	304 1.0×	78 0.6×	60 0.8×	6	2.0k
Tetsuro Sasada Japan	18	800 0.7×	1.2k 1.1×	434 1.4×	131 1.0×	43 0.6×	49	1.7k
Paolo Carrega Italy	23	922 0.8×	2.0k 1.8×	300 1.0×	136 1.0×	82 1.1×	40	2.5k
Dennis O. Adeegbe United States	18	845 0.7×	1.2k 1.1×	487 1.6×	232 1.7×	72 1.0×	31	1.9k
In-Hak Choi South Korea	8	915 0.8×	1.1k 0.9×	163 0.5×	113 0.8×	44 0.6×	8	1.4k
Maite Álvarez United States	25	1.0k 0.9×	1.5k 1.3×	357 1.2×	109 0.8×	43 0.6×	67	2.1k

Countries citing papers authored by Daisuke Sugiura

Since Specialization

Citations

This map shows the geographic impact of Daisuke Sugiura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Sugiura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Sugiura more than expected).

Fields of papers citing papers by Daisuke Sugiura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Sugiura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Sugiura. The network helps show where Daisuke Sugiura may publish in the future.

Co-authorship network of co-authors of Daisuke Sugiura

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Sugiura. A scholar is included among the top collaborators of Daisuke Sugiura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Sugiura. Daisuke Sugiura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murwanti, Retno, Kaori Denda‐Nagai, Daisuke Sugiura, et al.. (2023). Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells. Cancers. 15(6). 1920–1920. 4 indexed citations

Sugiura, Daisuke, Il‐mi Okazaki, Takumi Maruhashi, et al.. (2022). PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity. Nature Immunology. 23(3). 399–410. 57 indexed citations

Maruhashi, Takumi, Daisuke Sugiura, Il‐mi Okazaki, et al.. (2022). Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity. Immunity. 55(5). 912–924.e8. 129 indexed citations

Shimizu, Kenji, Daisuke Sugiura, Il‐mi Okazaki, et al.. (2021). PD-1 preferentially inhibits the activation of low-affinity T cells. Proceedings of the National Academy of Sciences. 118(35). 14 indexed citations

Shimizu, Kenji, Daisuke Sugiura, Il‐mi Okazaki, et al.. (2020). PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation. Molecular Cell. 77(5). 937–950.e6. 43 indexed citations

Maruhashi, Takumi, Daisuke Sugiura, Il‐mi Okazaki, & Taku Okazaki. (2020). LAG-3: from molecular functions to clinical applications. Journal for ImmunoTherapy of Cancer. 8(2). e001014–e001014. 316 indexed citations

Sugiura, Daisuke, Takumi Maruhashi, Il‐mi Okazaki, et al.. (2019). Restriction of PD-1 function by cis -PD-L1/CD80 interactions is required for optimal T cell responses. Science. 364(6440). 558–566. 285 indexed citations

Sugiura, Daisuke, et al.. (2019). PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Frontiers in Immunology. 10. 630–630. 123 indexed citations

Sugiura, Daisuke, et al.. (2019). Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation. Journal of Biological Chemistry. 294(15). 6017–6026. 79 indexed citations

10.

Okazaki, Il‐mi, et al.. (2019). PD-1 aborts the activation trajectory of autoreactive CD8+ T cells to prohibit their acquisition of effector functions. Journal of Autoimmunity. 105. 102296–102296. 12 indexed citations

11.

Maruhashi, Takumi, et al.. (2019). PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITR. Biochemical and Biophysical Research Communications. 511(3). 491–497. 7 indexed citations

12.

Maruhashi, Takumi, et al.. (2019). Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells. Journal of Biological Chemistry. 294(52). 19896–19906. 35 indexed citations

13.

Maruhashi, Takumi, et al.. (2018). LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII. Nature Immunology. 19(12). 1415–1426. 202 indexed citations

14.

Sato, Ryoichi, Yuka Madoka, Keiko Ikeda, et al.. (2017). Arabidopsis Phosphatidic Acid Phosphohydrolases Are Essential for Growth under Nitrogen-Depleted Conditions. Frontiers in Plant Science. 8. 1847–1847. 13 indexed citations

15.

Sugiura, Daisuke, Kaori Denda‐Nagai, Ryuichi Murakami, et al.. (2012). Local Effects of Regulatory T Cells in MUC1 Transgenic Mice Potentiate Growth of MUC1 Expressing Tumor Cells In Vivo. PLoS ONE. 7(9). e44770–e44770. 4 indexed citations

16.

Okazaki, Taku, Il‐mi Okazaki, Jian Wang, et al.. (2011). PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. The Journal of Experimental Medicine. 208(2). 395–407. 255 indexed citations breakdown →

17.

Denda‐Nagai, Kaori, Satoshi Aida, Saya Moriyama, et al.. (2010). Distribution and Function of Macrophage Galactose-type C-type Lectin 2 (MGL2/CD301b). Journal of Biological Chemistry. 285(25). 19193–19204. 67 indexed citations

18.

Sugiura, Daisuke, Kaori Denda‐Nagai, Kazuyoshi Takeda, & Tatsuro Irimura. (2010). Organ microenvironment plays significant roles through Fas ligand in vaccine‐induced CD4⁺ T cell dependent suppression of tumor growth at the orthotopic site. Cancer Science. 101(9). 1965–1969. 1 indexed citations

19.

Kamata‐Sakurai, Mika, Kaori Denda‐Nagai, Tomoko Itoh, et al.. (2010). Mucin 21/Epiglycanin Modulates Cell Adhesion. Journal of Biological Chemistry. 285(28). 21233–21240. 31 indexed citations

20.

Sugiura, Daisuke, Satoshi Aida, Kaori Denda‐Nagai, et al.. (2008). Differential effector mechanisms induced by vaccination with MUC1 DNA in the rejection of colon carcinoma growth at orthotopic sites and metastases. Cancer Science. 99(12). 2477–2484. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact